Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe
- OPACC
- 11 minutes ago
- 1 min read
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center investigators. This is the first larger scale study using a radiation-based direct drug delivery approach to treat and image DIPG.
Recent Posts
See AllA pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in...
Recent study results indicated that pediatric patients with acute lymphoblastic leukemia (ALL) were experiencing some motor skill impacts...
It may seem unusual to discuss future fertility when a family is reeling from the diagnosis of a child’s cancer. But 85% of children with...
댓글